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Summary 
Genes encoding the accessory  molecules CD8 and CD4 are activated early in thymocyte  development, 
generating CD4 +  8 + double positive intermediates, which give rise to two functionally distinct 
mature T cell subsets that express either CD4 or CD8. The mechanisms that govern the activation 
or suppression of the CD8 gene are likely to be central to the T  cell development program. 
To identify the key regulatory factors, we have initiated an analysis of the transcriptional regulation 
of the routine CDSc~ gene. We have identified three CD8 + cell-specific DNase I hypersensitive 
sites (HSS) located upstream of the routine CDSc~ gene. In vitro mobility shift analysis of the 
-4.0-kb HSS region has revealed multiple binding sites for the T  cell-restricted transcription 
factor GATA-3. In vitro translated routine GATA-3 binds specifically to both CD8 GATA sites, 
and coexpression of this factor in transient transfection assays transactivates  a reporter construct 
containing these sequences. These results provide the first evidence for the role ofa T cell-restricted 
factor in the regulation of either CD8 or CD4 genes. 
T 
he glycoprotein molecules CD4 and CD8, in conjunc- 
tion with the TCR, play an important role in T  cell 
antigen recognition and thymocyte development. The TCR 
mediates T cell recognition by contacting the antigenic pep- 
tide and polymorphic regions of the MHC, whereas CD4 
and CD8 act as coreceptors to stabilize the TCR-MHC in- 
teraction by associating with the TCR (1-3) and monomorphic 
regions of the MHC molecule (4, 5). In addition, CD4 and 
CD8 may provide transducing signals in developing and ma- 
ture T cells through the lymphocyte-specific  tyrosine kinase, 
p56  k~ (6-9).  Both the adhesion and signal transduction func- 
tions of the CD4 and CD8 molecules are likely to play a 
role in the maturation and selection of the T cell repertoire 
(10-13). 
CD4 and CD8 expression follow a complex, developmen- 
tally regulated pattern that has been best characterized during 
fetal thymic ontogeny (14). The earliest T cell precursors that 
populate the thymus do not express the TCK and have been 
termed double negative (DN) 1 thymocytes since they lack 
expression of both CD4 and CD8 molecules on the cell sur- 
face. DN thymocytes differentiate into double positive (DP) 
thymocytes that coexpress  CD4  and CDS,  together with 
TCR. At this stage of maturation, thymocytes bearing TCRs 
that can appropriately interact with MHC class I or II mole- 
1 Abbreviations used in this paper: CAT, chloramphenicol acetyl transferase; 
DN, double negative; DP, double positive; HSS, hypersensitive site; LCK, 
locus control region;  SP, single positive. 
cules are positively selected and further differentiate to be- 
come single positive (SP) cells that express either CD8 or 
CD4, respectively. Studies with transgenic mice expressing 
specific TCRs have provided compelling evidence that the 
TCR  specificity  determines the phenotype of developing 
thymocytes (15-18). Furthermore, indirect evidence indicates 
that the inactivation of either CD4 or CD8 during the DP 
to SP transition may occur in response to TCK-mediated 
signals (19, 20). Therefore, an analysis of CD4 or CD8 gene 
expression is expected to provide insight into the molecular 
mechanisms that positively activate the transcription of the 
coreceptor genes early in T cell development and those that 
negatively regulate their expression in cells destined to be- 
come mature CD4 or CD8 SP T  cells. 
Surprisingly,  very little is known about the regulation of 
the CD4 or CD8 genes. Recently, Sawada and Littman (21) 
have identified a T  cell-specific  enhancer flanking the rou- 
tine CD4 gene and Siu et al.  (22) have demonstrated that 
the CD4 promoter mediates in part,  the stage  and tissue 
specificity ofCD4 gene expression. We have initiated an analo 
ysis of the transcriptional regulation of the murine CD8o~ 
gene by searching for functional T cell-specific nuclear factor 
(NF) binding sites within developmentally regulated DNase 
I hypersensitive  sites (HSS) flanking the gene. The DNase 
I hypersensitivity assay has been successfully used to identify 
several tissue-specific enhancers (21, 23-26) and the complex 
locus control region (LCR) of the human B-globin locus 
(27-29).  We  have  identified three  CD8 +  T  cell-specific 
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of protein-DNA interactions by in vitro mobility shift anal- 
ysis has identified multiple binding sites for a T cell-restricted 
transcription factor GATA-3 (30-34), within a HSS domain 
located 4 kb 5' of the CD8 gene. We show that coexpression 
of the routine GATA-3 gene results in transcriptional activa- 
tion of a reporter plasmid dependent on CD8 GATA sequences, 
suggesting that these sites are functional. Our results pro- 
vide the first evidence for a T cell-restricted transcription factor 
regulating coreceptor gene expression. 
Materials and Methods 
Cell Lines.  Murine thymoma cell lines AKR1G1 (CD4+8 +) 
and NFC105 (CD4 +  8 +) were from Dr. Kenneth Rock (Harvard 
Medical  School,  Boston,  MA);  322E-9A10 (CD4+8 §  and 
S802MC4F10 (CD4-8 ~) were from Dr. Ellen Pdtchie (University 
of  Texas, Smithville,  TX);  AKR.5 (CD4+8 -)  and  AKR33 
(CD4+8 *) were from Dr.  Harald yon Boehmer (Basel Institute 
for Immunology, Basel, Switzerland); and RLMll (CD4+8 -) and 
EL-4 (CD4-8-).  Murine  cell lines used  were  pre-B cell lines 
70Z/3, 38B9, and HAFTL; B cell lines AJ9 and WEHI 231; and 
fibroblast cell line NIH3T3. Human cell lines HeLa (cervical  carci- 
noma) and fibrosarcoma 164 (FS) were also used. All lymphoid 
cells were grown in RPMI 1640 medium supplemented with 10% 
inactivated FCS, 0.0002% B-ME, penidllin, and streptomycin.  Non- 
lymphoid cells were grown in DME medium supplemented with 
10% calf serum,  penicillin, and streptomycin. 
Flow Cytometric Analysis ofT Cell Lines.  All murine thymoma 
cell lines were analyzed for CD4/L3T4 and CD8/Lyt2 expression 
by flow cytometry  using rat mAbs GK1.5 and 53-6.72, respectively. 
Cells were labeled using primary Abs derived from cell culture su- 
pernatant followed by FITC goat anti-rat IgG (Tago, Inc., Burlin- 
game, CA). 
DNase I Hypersensitivity Assay.  Nuclei were isolated as follows: 
6  x  107 cells were washed in PBS and then treated with reticulo- 
cyte standard buffer (ILSB)  (10 mM Tris-HC1, pH 7.4, 10 mM NaC1, 
and 3 mM MgC12) with 0.5% NP-40 on ice for 5 rain. The nuclei 
were pelleted, washed in RSB without NP-40, and resuspended 
in 0.5 ml of RSB. 100/~1 of nuclear suspension was treated with 
various amounts of DNase I for 2 min at 37~  The reaction was 
quenched with 120 ktl of RSB containing  2% SDS and 10 mM 
EDTA, and digested with 40 /xg of proteinase K,  followed by 
purification with several phenol and chloroform extractions and 
precipitation with 3 M NaOAc, pH 5.2. The genomic DNA was 
dissolved in 100/xl of TE 10 mM Tris, ImM EDTA, treated with 
25/xg ILNase for 3 h, and precipitated after several  extractions with 
phenol  and chloroform.  12-15 /zg of DNase-treated  DNA was 
digested with the appropriate restriction endonucleases, and ana- 
lyzed by Southern blotting using random-primed DNA probes. 
Plasmids.  Plasmid  HN2 contains the murine genomic CD8c~ 
gene and was a gift from Dr. J. Parnes (Stanford University Med- 
ical Center, Stanford, CA) (35). The mammalian expression con- 
structs R/mGATA sense and IL/mGATA  antisense contain the mu- 
rine GATA-3 cDNA driven by the tLous sarcoma virus promoter 
and enhancer (31). Plasmid mc5b8 contains the murine GATA-3 
cDNA clone (31). P14 contains the 9.0-kb genomic BamHI frag- 
ment from the genomic clone, G3-1-1A, cloned into the BamHI 
site of pGEM3zf(-) (Promega Corp.,  Madison, WI). P20 con- 
tains a 478-bp Sau3AI DNA fragment encompassing the -4.0-kb 
HSS, cloned into the BamHI site of  Bluescript (M13-) (Stratagene, 
La Jolla, CA). The insert was completely sequenced and restriction 
sites were identified to generate subfragments for in vitro mobility 
shift assays. 
Wild type and mutant oligonucleotides from probe 3 were syn- 
thesized with  SalI/XhoI ends  (mutations  are underlined):  P3, 
TCGAGTGATAGAATAGATAGCAG;  P3-M1, TCGAGTGATAGA- 
ATCTGCAGCAG;  and  P3-M2,  TCGAGTTCTAGAATCTGC- 
AGCAG. The double-stranded  oligonucleotides were cloned as 
dimers (head-to-tail) into the SalI site of A56fos-CAT, in which 
the bacterial chloramphenicol  acetyl transferase  reporter gene (CAT) 
(36) is transcribed from a minimal c-~s gene promoter and named 
(P3)-CAT, (P3-M1)-CAT,  and (P3-M2)-CAT, respectively.  Each con- 
struct was sequenced using a primer (GCAGAGCTGGGTGGG- 
AGCGCGGTC) corresponding to nucleotides + 72 to + 95 of the 
c-Jos promoter by the dideoxy-chain termination  method. 
Cloning and Sequencing of Upstream CD8 Sequences.  A 730-bp 
HindlII-EcoRI CD8 probe, derived from plasmid HN2, was used 
to screen a mouse genomic library from a T cell hybridoma line 
derived from:  AKR  x  B10.A (Dr. A.  Winoto,  University of 
California, Berkeley, CA).  A 9.0-kb  BamHI fragment,  encom- 
passing the -4.0 and  -2.0 -kb HSS regions, was subcloned from 
the positive phage clone G3-1-1A. The 5' DNase I hypersensitive 
site regions were mapped,  subcloned, and sequenced using  the 
dideoxy-chain termination  method. 
Probes.  Probe 2 is a 61-bp HaelII/DdeI fragment and probe 
3 is a 48-bp AluI/Sau96I fragment from plasmid P20. The GATA-3 
binding sites identified within these fragments are separated by 56 
nucleotides, with the probe 2 site located further 5' relative to the 
CD8c~ gene. 
In Vitro Analysis of DNA-Protein Interactions.  The DNA probes 
were prepared by cutting plasmid P20 with restriction enzymes 
and endlabeling with polynucleotide kinase. In vitro binding reac- 
tions were performed as previously described (37) using 2 ng of 
labeled DNA probe, 10/xg of crude nuclear extract (38), and 2-3 
~g of poly(dI-dC) (Pharmacia, Piscataway, NJ). For competition 
experiments, increasing amounts  of unlabeled DNA probe were 
included in  the binding  reaction  in  a 15 /zl final volume. The 
resulting protein DNA complexes were separated on a 4% poly- 
acrylamide gel. The GATA-3  protein was generated by in vitro tran- 
scribing mRNA from plasmid mcSb8 (Stratagene)  and in vitro trans- 
lating  the protein in wheat germ extract  (Promega Corp.). 
Methylation Interference Assay.  Methylation interference  was per- 
formed as previously described (39). Briefly, an end-labeled DNA 
probe was partially methylated with dimethyl sulfate and used in 
preparative  in  vitro  binding  assays. DNA  retained  in  the 
nudeoprotein complex and in the flee fragment was isolated, cleaved 
with piperidine, and analyzed by electrophoresis through urea- 
containing  sequencing gels. 
Cotransfections and CATEnzyme Analysis.  10 #g of  reporter con- 
struct ([P3I-CAT, [P3-M1]-CAT, [P3-M2]-CAT, or A56fos-CAT) 
and 5 gg of transactivator (R/mGATA sense or IL/mGATA an- 
tisense) were cotransfected into 1-2  x  10  ~ HeLa cells. Transient 
transfections were carried out using the calcium phosphate method 
(40) and were repeated at least twice in duplicate. Cell extracts 
were prepared from transfected cells 48 h later and 80-100/zg of 
cell extract was assayed for 1.5 h as previously described (41). 
Results 
CD8 Expression-specific Hypersensitive Sites 5' to tke Murine 
CD8cr Gene.  To identify potential transcriptional regula- 
tory domains important for CD8 gene expression, we ana- 
lyzed the chromatin structure of this locus by partial DNase 
I digestion. Nuclei prepared from T cells expressing, or not 
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Presence of HSS  within  the Murine  CDSce Locus 
DNase I  HSS 
T  cell  line  CD4  CD8  -  4.0  -  2.0  + 1 
AKR.1GI*  +  +  + *  +  + 
AKR33  +  +  +  +  + 
9A10  +  +  +  +  _+ 
4F10  -  +  +  +  + 
AKR5  +  .... 
RLM11  +  .... 
EL-4  ..... 
" T cell lines were analyzed for CD4 and CD8 surface  expression  by an- 
tibody staining and flow cytometry. 
DNase 1 HSS were identified as described in Materials and Methods. 
Figure  1.  Three CD8 expression-specific  HSS map upstream of  the mu- 
rine CDSc~ gene. (A) Restriction map of the murine CD8ot gene and 
a schematic representation of the  -4.0 and  -2.0 -kb hypersensitive  sites 
contained within  the genomic clone G3-1-1A. The three hypersensitive 
sites were identified using a 730-bp HindlII-EcoRI fragment (probe  A) 
and verified  using a 1.2-kb BamHI-HindlII fragment (probe  B). The 9.0- 
kb clone G3-1-1A  was obtained using probe A. (Boxed  regions)  CD8 exons; 
and restriction sites for BamHI (B), HindlII (n), and EcoRl (R). (/3)  Anal- 
ysis of DNase I HSS in the 5' flanking region of the murine CD8 gene. 
Nuclei from the T  cell lines: AKR1G1 (CD4+8 +, lanes 1-5),  AKR5 
(CD4+8 -,  lanes 6-9),  and  AKR33  (CD4+8 +,  lanes I0-I4),  were 
digested with 0.1 #g (lanes 2, 6, and 11), 0.2/zg (lanes 3, 7, and 12), 
0.3/~g (lanes 4, 8, and 13), or 0.4/xg (lanes 5, 9, and I4) of DNase 1 
in a final volume of 0.1 ml for 2 min at 37~  Lanes I and 10 are not 
treated with DNase I. The DNA was purified, digested with BamHI, 
electrophoresed through a 1% agarose gel, transferred to nitrocellulose, 
and probed with probe A. (Arrows) HSS. 
expressing, the CD8 gene were treated with increasing con- 
centrations of DNase I followed by analysis of BamHI-digested 
genomic DNA by Southern blotting (Fig. 1 B). The 730-bp 
HindlII-EcoRI  fragment  (Fig.  1  A,  probe  A)  detects  a 
9.0-kb  BamHI  genomic fragment.  In  the  CD4+8 +  DP T 
cell lines, AKR1G1 and AKR33, three additional bands were 
observed in the lanes containing DNase I-digested DNA, in- 
dicating  the presence of DNase  I  HSS.  Two of these HSS 
mapped 4.0  and  2.0 kb upstream  of the CD8cr  coding se- 
quences, whereas the third site mapped close to the CD8ot 
gene  transcription  initiation  start  site  and  is likely to cor- 
respond  to  the  promoter  region.  The  Southern  blot  was 
reprobed with an upstream 1.2-kb BamHI-Hind III fragment 
(probe B in Fig.  1 A) to confirm the location of each hyper- 
sensitive site (data not shown).  To determine if the presence 
of these HSS correlated with CD8 gene expression, a panel 
of T cell lines displaying different expression patterns of CD4 
and CD8 were examined by the DNase I assay (Table 1). All 
three HSS were observed only in cell lines that expressed the 
CD8  gene,  and not in CD4 +  8-  SP cell lines,  nor in EL-4 
cells that express neither CD4 nor CD8. The CD4 and CD8 
expression pattern was confirmed by flow cytometry (sum- 
marized in Table 1).  The consistent link between CD8 cell 
surface expression and the identified hypersensitive sites sug- 
gested that  these  sequences may play an important  role in 
the  regulation  of the  CDSa  gene. 
Interaction  of a  T  Cell-specific  Factor  with  the  -4.0-kb 
HSS.  Although  DNase I HSS often mark  the location of 
functional enhancers, e.g., the Ig h chain gene enhancer (23) 
and the human CD2 enhancer (24), there are other cases where 
a combination of HSS is required to detect significant tran- 
scriptional enhancer activity. The best characterized example 
is  the LCR of the B-globin locus,  where four HSS spread 
over 20 kb are required to confer high level, position inde- 
pendent,  tissue-specific expression on the B-globin gene or 
a linked heterologous gene (27-29).  However, each hyper- 
sensitive region analyzed contains multiple binding sites for 
an erythroid-specific transcription factor (42-46), that has now 
been shown to be critical for erythroid differentiation (47). 
We postulated that one way to identify factors necessary for 
CD8 gene expression would be to search for T  cell-specific 
factors that bound within the CD8 hypersensitive domains. 
Of the three newly identified DNase  I  HSS,  one corre- 
sponds  to  the promoter region  of the  CD8  gene  and  two 
others represent potential upstream regulatory elements. To 
identify nuclear factors that may be important for the regu- 
lation of the CD8 gene, we carried out in vitro DNA-pro- 
tein binding assays. A 9.0-kb fragment ofgenomic DNA con- 
taining both upstream HSS was cloned and 50-100-bp DNA 
fragments spanning "~500 bp around the two CD8 upstream 
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tein binds to two adjacent  DNA fragments 
from the  -4.0-kb HSS. (A) Nuclear pro- 
tein  extracts  were  prepared  from  a 
CD4+8 - T cell line, AKRS, and tested in 
a gel mobility shift assay  for binding to ra- 
dioactively labeled DNA probes 2 (lanes 
I-7) and 3 (lanes  8-14). Bindings  were  per- 
formed in the absence  of  competitor DNA 
(lanes I  and 8) or in the presence of 50- 
or 100-fold  molar excess  of unlabeled non- 
radioactive DNA: probe 2 (lanes 2, 3 and 
11,  12), probe 3 (lanes 4, 5 and 9, 10),  or 
nonspecific DNA (lanes 6, 7 and 13,  14). 
To examine  the tissue distribution of  com- 
plex 2 (B) and complex 3 (C), nuclear ex- 
tracts were prepared from various murine 
B and T cell lines and tested by gel mo- 
bility shift assay using a radioactively  la- 
beled AluI/AluI subfragment of probe 2, 
or probe 3, respectively.  The cell  lines used 
and their expression  patterns  are noted above 
each lane and the specific  complexes  are in- 
dicated with arrows. Probe 2 generates an 
additional nonspecitic  (upper)  complex  that 
is present in all cell extracts examined. To 
separate the specific  and nonspecific  com- 
plexes, this gel was run for a longer time. 
HSS were radiolabeled, incubated with nuclear extracts, and 
analyzed by electrophoresis through nondenaturing polyacryl- 
amide gels. Nucleoprotein complexes were identified by their 
slower mobility compared with the free probe during elec- 
trophoresis  and  sequence specificity of the interaction was 
confirmed by competition  experiments. 
One DNA fragment from the  -2.0-kb HSS region showed 
several specific nucleoprotein complexes by gel shift assay, sug- 
gesting a cluster of binding sites within this fragment. How- 
ever, preliminary analysis of the tissue distribution of the factors 
generating these complexes did not reveal T  cell-specific pro- 
tein-DNA  interactions  and  therefore, we have not  further 
analyzed this fragment (data not shown). Two adjacent DNA 
fragments,  probes 2  and 3,  from within  the  -4.0-kb  HSS 
domain, revealed specific nucleoprotein complexes (complexes 
2  and 3,  respectively, are indicated by arrows,  Fig.  2 A) in 
extracts derived from both CD4+8 +  DP and CD4+8 -  SP 
T  cell lines.  Since the complexes had  similar  mobility,  we 
tested whether they represented binding of the same nuclear 
factor to both probes by crosscompetition experiments (Fig. 
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to the GATA binding motif. Nuclear protein extract from AKR5 was in- 
cubated with partially  methylated probe 2 (A) or probe 3 (B) and electro- 
phoresed through a 4% nondenaturing acrylamide gel. Complex 2 or 3 
was excised from the gel, as well as the free fragment. The duted DNA 
was cleaved with piperidine and analyzed on a 12% sequencing  gel (~) 
G or A residues which make close contact with the nuclear  protein (F, 
free probe; B, bound probe). (C) Sequence comparison between the re- 
gion of protein contact in complexes 2 and 3, and GATA sequences from 
globin genes (42, 46).  (~,-) Nucleotide residues detected by methylation 
interference; (vertical bars) regions of homology between shown sequences; 
(horizontal  bar) a potential GATA site which does not score in this assay. 
2 A). Complex 2 was competed efficiently by including non- 
radioactive probe 2 or 3 DNA in a binding reaction (Fig. 
2 A, lanes 2-5). A comigrating nonspecific complex was re- 
vealed when complex 2 was competed away (Fig. 2 A, lanes 
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2-5).  Conversely, complex 3 was competed by nonradioac- 
tive probe 2 and probe 3 DNA, albeit probe 2 competed some- 
what less efficiently (Fig. 2/1, lanes 11-12). Neither the probe 
2  nor  the probe  3  complex was  competed by equivalent 
amounts of an irrelevant DNA (Fig. 2/1, lanes 6, 7 and 13, 
14, respectively),  showing that the nucleoprotein complex 
represented the specific interaction of nuclear factor(s) with 
DNA. Furthermore, these results indicated that the same factor 
may bind to both probes. 
To  determine the  tissue distribution  of the probe  2/3 
binding protein and to further confirm their similarity,  we 
examined a panel of extracts derived from B and T lymphoid 
cell lines and several nonlymphoid cell lines. Both probes de- 
tected a factor in all T cell lines assayed, irrespective of their 
status  of CD4 or CD8 expression  (Fig.  2, B  and C, lanes 
1-8). This factor was absent in the three pre-B, two mature 
B, and in the nonlymphoid cell lines HeLa or FS (Fig.  2 B 
and C, lanes 9-16). Although both probes generated a com- 
plex with NIH3T3 cell extracts  (Fig. 2, B and C, lane 15), 
we believe that the factor responsible  is different from that 
detected in T  cell extracts  based on the slower mobility of 
this complex and the lack of GATA-3 mRNA in these cells 
(data not shown, see below). Equivalent amounts of cell ex- 
tract were analyzed as determined  by assaying for the ubiqui- 
tous octamer binding protein (data not shown). Thus, probes 
2 and 3 bind a protein that is restricted to T lymphoid ceUs. 
GATA-3 Binding Sites within the -4.0-kb Hypersensitive  Re- 
gion.  To precisely map the site of DNA-protein interactions, 
we used methylation interference  assays. This assay detects 
G  and  A  residues  whose  methylation  interferes  with 
DNA-protein interaction and therefore, are absent from DNA 
eluted from the nucleoprotein complex band of a preparative 
dectrophoretic mobility shift gel. On the noncoding strand 
of probe 2,  two G  and two A  residues  were significantly 
depleted in the bound DNA lane (Fig.  3 A) identifying a 
sequence element GATTAATGA. On the noncoding strand 
of probe 3, bands corresponding to five  purine residues were 
diminished in the bound DNA lane (Fig. 3 B), identifying 
the sequence AGATAG. The sequences which scored in this 
assay bear significant homology to sequences identified in the 
human 3-globin enhancer (42) and the A3,-globin promoter 
(46) (Fig. 3). These sequences bind the erythroid-specific tran- 
scription factor NF-E1, EryF-1, or GATA-1 (30, 42, 43). We 
conclude that a T cell-specific nuclear factor recognizes a site 
similar to that seen by the GATA-1 protein, and binds to two 
sites within the - 4.0-kb HSS upstream of the murine CD8 
gene. 
Recently, a search for genes encoding GATA-1 related pro- 
teins by low stringency hybridization has led to the identi- 
fication of two related genes, GATA-2 and GATA-3. GATA-1 
is expressed exclusively  in erythroid cells, GATA-2 is expressed 
at low levels  in erythroid cells and other cell types, and GATA-3 
is expressed predominantly and abundantly in T  lymphoid 
ceils and to a lesser extent in fetal brain (30-34). This pattern 
of expression suggested the possibility that the T cell-restricted 
factor detected in nuclear extracts was the GATA-3 protein. 
To determine  if GATA-3 protein can bind to the CD8 GATA 
sites in probes 2 and 3, we synthesized this factor by in vitro Figure 4.  GATA-3  protein binds specifically  to probe  3 and comigrates 
with the cellular nucleoprotein complex 3. Nuclear protein extract from 
9A10, a DP T cell line (lanes 1-5), or in vitro translated GATA-3 (lanes 
6-10) was incubated with radioactively  labeled  probe 3 and examined by 
the electrophoretic  mobility  shift assay. Competitions  were  performed  with 
100-fold  molar excess  of nompecific  DNA derived  from the octamer  binding 
site in lanes 2 and 7; a dimer of the P3 oligonucleotide  containing the 
wild-type probe 3 GATA sequence  (lanes 3 and 8); a dimer of the P3-M1 
oligonudeotide containing mutations in a single GATA site (lanes 4 and 
9); or a dimer of the P3-M2  oligonucleotide  containing two mutated  GATA 
sites (lanes 5 and I0). 
transcription and translation of the murine GATA-3 gene and 
carried out binding analyses. Incubation of either radiolabded 
probe 2 (data not shown) or probe 3 DNA with wheat germ 
extracts containing in vitro translated GATA-3 protein, gener- 
ated a nucleoprotein complex (Fig. 4, lane 6) which comigrated 
with the cellular protein in complex 3 (Fig.  4, lane 1). Both 
the cellular complex and the in vitro translated GATA-3 pro- 
tein complex were competed specifically by oligonucleotides 
containing  the probe 3 GATA site (Fig.  4,  lanes 3  and 8), 
but not by irrelevant DNA containing the octamer binding 
site (Fig.  4, lanes 2 and 7).  Surprisingly,  an oligonucleotide 
containing a mutation in the GATA site identified by meth- 
ylation  interference  (P3-M1)  was also able to compete for 
GATA-3 binding (Fig.  4, lanes 4 and 9). Competition anal- 
yses using lower levels of competitor DNA showed that the 
M1  mutation  competed two-threefold less efficiently than 
the wild-type competitor (P3) (data not shown), suggesting 
the presence of an adjacent, lower affinity GATA binding site 
within the oligonucleotide sequence. Oligonucleotides con- 
taining  a second mutation  (P3-M2) in  the  adjacent  GATA 
consensus site in probe 3 did not compete for cellular com- 
plex 3 and in vitro translated GATA-3 binding (Fig.  4, lanes 
5 and 10). In addition, neither probe 2 nor probe 3 generated 
a complex when incubated with wheat germ translation ex- 
tracts  alone  or with  in vitro  translated  p50,  a component 
of the transcription  factor NF-xB (data not shown).  Taken 
together, the results of the in vitro binding analysis indicate 
that the T cell-restricted GATA-3 protein interacts with sev- 
eral elements located within the  -4.0-kb DNase I HSS and 
suggests that  this factor may play a role in CD8o~ gene ex- 
pression. 
Functional Analysis of the CD8 GATA Binding Site  GATA-1 
has been identified as the critical factor required for erythroid- 
specific expression of various globin and nonglobin genes and 
erythroid differentiation  (47, 49). Recently, functional GATA-3 
binding sites have been identified in the regulatory sequences 
of T cell-specific genes such as the TCRs c~, ~, and ~ (31-34). 
In all cases, the functional significance of the GATA dements 
have been inferred from the observation that  multimerized 
GATA sites activate transcription  from a minimal promoter 
in the presence of coexpressed GATA protein.  To determine 
if the CD8ot gene GATA sites were active in such an assay, 
an  oligonucleotide containing  CD8 GATA sequences from 
probe 3 was cloned as a dimer upstream of a minimal c-./bs 
gene promoter driving the CAT gene. As a control,  an oli- 
gonucleotide containing a mutation in the GATA site identified 
by methylation interference was also cloned as a dimer into 
the same vector. For transactivation assays, each plasmid was 
cotransfected into nonlymphoid HeLa cells with a plasmid 
expressing the murine GATA-3  cDNA (R/mGATA sense). 
GATA-3  is not  detectable in  HeLa ceils  as determined  by 
Northern blots probed with mc5b8 cDNA (data not shown). 
The  transfected cells were harvested 48 h later and cellular 
extracts assayed for CAT enzyme activity. Plasmid (P3)-CAT, 
containing  the wild-type GATA site from probe 3,  showed 
16-fold greater  activity in the presence of the GATA-3 ex- 
pression vector compared with a vector containing the gene 
in the opposite orientation (Fig. 5). Plasmid A56-CAT lacking 
CD8 GATA sites and plasmid (P3-M1)-CAT carrying a single 
mutated GATA site were only 1.5- and &l-fold more active 
in the presence of the GATA-3 cDNA expressing vector. The 
20 
o= 
mGATA-3 
A56fos-CAT  0P3)-CAT  (P3-MI)-CAT  (P3-M2)-CAT 
+  +  +  + 
Figure  5.  GATA-3  transactivates CD8 GATA sites in a cotransfection 
assay. HeLa  cells  were  transiently transfected  with 10/xg of reporter plasmid 
(A56fos-CAT, [P3]-CAT, [P3-M1]-CAT, or [P3-M2]-CAT) and 5/~g of 
transactivator mGATA-3  sense (+) or antisense (-). Fold  induction is cal- 
culated as the ratio of  percent chloramphenicol  conversion  with mGATA-3 
sense to mGATA-3 antisense. 
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M1)-CAT could be due to the adjacent GATA consensus se- 
quence present within the P3 oligonucleotide (refer to Fig. 
3 C). This idea was consistent with the results from the com- 
petition experiments (Fig. 4) and was further confirmed by 
the transfection  experiments using an oligonucleotide con- 
taining a mutation in the second GATA site cloned into the 
CAT containing plasmid,  (P3-M2)-CAT. In this case, the 
GATA-3 inducible activity was drastically affected (Fig. 5). 
Thus, the GATA sites in the CD8oe gene -4.0-kb HSS are 
functional by the same criteria that has been used for such 
sequences from the globin genes (30, 44, 45, 48) or the TCR 
a,  3,  and c5 genes (31-34). 
Discussion 
We report the first analysis of factors that may regulate 
the transcription of the murine CD8c~ gene. We proceeded 
by searching for CD8 expression-specific DNase I HSS in 
the CD8c~ locus, analyzing such regions for interesting (T 
cell-specific)  regulatory protein binding sites, and finally, 
testing those sites for their ability to act as transcriptional 
activators.  Three DNase I HSS were identified in DP and 
CD4-8 + SP T  cell lines. Multiple binding sites for a T 
cell-specific factor were detected within the distal HSS, which 
maps approximately 4.0-kb upstream of the transcription ini- 
tiation start site of the murine CD8oe gene. High resolution 
mapping of the binding sites for these factors by methylation 
interference assays showed them to be homologous to previ- 
ously identified  sites in regulatory regions  associated with 
various globin genes, which bind the erythroid-specific tran- 
scription factor, GATA-1. A T cell-restricted member of the 
GATA gene family, called GATA-3, has been cloned and shown 
to recognize similar consensus sequences found within the 
TCR 06 3, and/t chain gene enhancers. We show that in 
vitro translated GATA-3 protein binds to multiple CD8 GATA 
sites and propose that the T cell-specific factor we detect in 
nuclear extracts is the cellular GATA-3 protein based on the 
following evidence: (a) the equivalent mobilities of the cel- 
lular protein and in vitro translated GATA-3; (b) the indis- 
tinguishable sequence specificity  of both proteins; (c) the pres- 
ence of GATA-3 mRNA in all T  cell lines tested (Landry, 
D.  B., and R. Sen, unpublished  data) and; (d) the absence 
of other GATA factors in T lymphocytes (Leonard, M. W., 
and J.  D.  Engel,  unpublished  data). 
GATA binding proteins were first identified as erythroid- 
specific factors that bound within the regulatory sequences 
of chicken and human globin genes (42-46). Both the LCR, 
which regulates copy number-dependent, integration site-in- 
dependent expression  of globin genes, and the individual globin 
gene promoters contain multiple binding sites for the ery- 
throid-specific GATA-1 protein.  Although a critical role for 
GATA-1 in erythroid differentiation has been unequivocally 
demonstrated by gene disruption methodology (47), it has 
proved difficult to directly demonstrate the functional signi- 
ficance  of most of these sites in the context of the whole regula- 
tory sequence. To circumvent this problem, GATA sites have 
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been analyzed individually or as multimers cloned upstream 
of a minimal TATA box containing promoter. For example, 
the functional significance of GATA sites in the TCR 06 3, 
and ~ enhancers  have  been judged based on the ability of dimer- 
ized sequences to activate transcription  (31-34).  Similarly, 
GATA motifs from DNase I HSS associated  with the 3-globin 
LCR have also been studied by transactivation of multimer- 
ized elements by coexpression of the GATA-1 cDNA. Such 
results with diverse GATA-containing regulatory sequences 
suggests that the function of these elements may not be readily 
determined by standard enhancer assays. Given the complex- 
ities of GATA site-dependent transcription,  we assayed the 
CD8 GATA sites from the -4 kb HSS as a dimer upstream 
of a minimal c-fis gene promoter. This CD8 sequence acti- 
vates transcription  strongly when cotransfected  with  the 
GATA-3 gene into nonlymphoid cells, suggesting  that the 
sites are functional and therefore, may play a role in the tran- 
scriptional  regulation of the murine CD8c~ gene. 
Does this T cell-restricted factor satisfy the various criteria 
expected of a critical regulator of CD8 gene expression during 
thymocyte  differentiation? The developmental  pattern of CD8 
expression suggests at least two levels of regulation.  First, 
the CD8 gene is activated as thymocytes progress from DN 
to DP cells and second, it is inactivated in cells that are posi- 
tively  selected by class II MHC  molecules.  The GATA-3 
binding sites that we have identified are located within a CD8- 
specific DNase I HSS, consistent with a role for this factor 
in the regulation ofCD8 gene expression. However, two lines 
of evidence indicate that the properties  of GATA-3 are not 
sufficient to accommodate all the regulatory complexities of 
the CD8 gene. First, the factor we detect in nuclear extracts 
(likely to be the product of the GATA-3 gene) is present in 
both DP and CD4 +  8-  SP T cell lines, suggesting  that the 
lack of CD8 expression in the later cells is not due to the 
absence of this factor. Second, our preliminary results of ex- 
periments investigating the onset of GATA-3 mRNA expres- 
sion during fetal thymocyte ontogeny shows that this gene 
is  transcribed  as early as day 13/14  of gestation  (Landry, 
D. B., and K. Sen, unpublished  data), preceding the onset 
of CD8 protein expression which occurs around day 16/17 
of gestation (50). We speculate that T cell specificity, as well 
as stage specificity within the lineage, may be achieved by 
GATA-3 protein  acting  in  concert with  other currently 
unidentified regulatory proteins. This model provides a mech- 
anism by which different stage-specific T cell genes may be 
regulated by both GATA-3 and other stage-specific factors. 
It is interesting to point out some parallels between the 
regulation of the 3-globin locus and the CD8 gene. First, 
the 3-globin locus is believed to be regulated in part by the 
erythroid-specific factor GATA-1, since functional GATA-1 
binding sites have been found within the 3-globin LCK HSS 
and promoter HSS regions. Similarly, we have identified func- 
tional GATA-3 binding sites within the CD8-specific -4.0-kb 
HSS and, as well as, within the CD8c~ promoter HSS region 
(Mittal,  P., D. Landry, and R. Sen, unpublished results). In 
both cases, additional  tissue-specific factors are likely to be 
required.  Second, switching to other 3-type globin genes 
occurs by the suppression of the earlier genes despite the con- tinued presence of GATA-1. Similarly, whereas GATA-3 may 
play a role in the activation of the CD8o~ gene, it continues 
to be expressed in the later CD4 +  8-  SP lineage.  Finally, the 
LCR of the/3-globin locus is spread over many kilobases of 
DNA and is composed of four tissue-specific  DNase I HSS, 
the most proximal of which is located only 6.0-kb upstream 
of the e-globin gene. A  combination of these four HSS is 
required to achieve high-level, tissue-specific  expression of 
globin genes. In the CD8 locus, the HSS we have character- 
ized is approximately 4.0-kb upstream from the transcrip- 
tion initiation site of the CDSo~ gene, and we speculate that 
this HSS will act in concert with other presently unidentified 
regulatory HSS. 
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